Adverum Biotechnologies Announces Pricing of $60 Million Public Offering of Common Stock Biotech Investing
Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis Pharmaceutical Investing
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation Biotech Investing